NNOX · Nano-X Imaging Ltd.
$1.12
+0.08 (+7.69%)
At close · Jul 17
Market Cap
$77.95M
Shares
69,600,783
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.12
Open$1.04
Day$1.02–1.14
52W$0.73–5.69
Avg vol 30d3.0M
Short int7.2M · 10.3% float · 1.1d
Short vol62%
Last earningsSep 30, 2025
DataAug 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.8 · elevated
Equity put/call 0.73
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−57%
below
Price vs 50-day avg
−29%
below
RSI (14)
40
neutral
MACD trend
Positive
52-week position
8%
near low
Momentum
relative strength
1-month return
−35%
trailing
6-month return
−66%
trailing
YTD return
−60%
this year
Relative strength
−74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
13 of 127 funds reported for Jun 30 · net +24.7K sh shares · +1 new
Insider flow
Distributing
Net -$1.1K over 90 days · 100% sells
Short interest
Falling
10.30% of float · ▼ -16.2% MoM · 1.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
127 holders — mid 3-yr range
Squeeze score
54
elevated · 0–100
Fundamentals
Revenue growth
+15%
Y/Y
Gross margin
-98%
contracting
EPS growth
−27%
Y/Y
Free cash flow
$-45.0M
Balance sheet
$42.6M
net cash
Quant / Vol
risk profile
Volatility
93%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
12.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Dec 31, 2025
Revenue
· full year of 2026
Initiated
$35M
prior FY $13.02M
midpoint +168.8% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−57%
Bearish
Price vs 50-day avg
−29%
Bearish
RSI (14)
40
Neutral
MACD trend
Positive
Bullish
52-week position
8%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
13 of 127 funds reported for Jun 30 · net +24.7K sh shares · +1 new
Insider flow
Distributing
Net -$1.1K over 90 days · 100% sells
Short interest
Falling
10.30% of float · ▼ -16.2% MoM · 1.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
127 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 8%
52-wk high $6
vs 200-day avg -57%
vs 50-day avg -29%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NNOX
this stock
Nano-X Imaging Ltd.
|
$77.95M | -60.0% | +15.5% | — | 10.3% |
|
ABT
Abbott Laboratories
|
$175.37B | -19.2% | +5.7% | 28.2 | 1.3% |
|
SYK
Stryker Corp
|
$122.63B | -8.7% | +11.2% | 37.0 | 1.8% |
|
MDT
Medtronic plc
|
$106.50B | -12.7% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.44B | -53.8% | +5.5% | 18.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NNOX | +6.7% | -35.3% | -66.1% | -3.5% | -60.0% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | +8.2% | -35.6% | -73.9% | -3.0% | -69.0% |
Key facts
CIK
1795251
CUSIP
M70700105
13F (30d)
13 filings
12 filers
Visit website
Investor relations